Publikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Biomédica de Salamanca (18)

2024

  1. Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients

    Blood cancer journal

2023

  1. Extranodal natural killer/T-cell lymphoma nasal type in a western population: Molecular profiling identifies new therapeutic targets

    American Journal of Hematology

  2. Intermediate Molecular Phenotypes to Identify Genetic Markers of Anthracycline-Induced Cardiotoxicity Risk

    Cells, Vol. 12, Núm. 15

  3. Primary Cutaneous Marginal Zone Lymphoproliferative Disorder of Donor Origin after Allogeneic Hematopoietic Stem Cell Transplantation

    American Journal of Dermatopathology, Vol. 45, Núm. 6, pp. 378-382

2022

  1. ABCL-297 Hemophagocytic Lymphohistiocytosis Singularity: A Multicenter Retrospective Study

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S369-S370

  2. CT-169 Cytokine Release Syndrome After Peripheral Blood Haploidentical Stem Cell Transplantation With Post-Transplant Cyclophosphamide: Time of Onset Matters

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S437-S438

  3. Ibrutinib in Combination With Rituximab for Indolent Clinical Forms of Mantle Cell Lymphoma (IMCL-2015): A Multicenter, Open-Label, Single-Arm, Phase II Trial

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 40, Núm. 11, pp. 1196-1205

  4. TCL-318 Evaluation of the Antitumor Activity of Amiloride in Peripheral T-Cell Lymphomas Using In-Vitro Models

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S399

2020

  1. Avadomide monotherapy in relapsed/refractory DLBCL: safety, efficacy, and a predictive gene classifier

    Blood, Vol. 135, Núm. 13, pp. 996-1007

2018

  1. A novel FAS mutation with variable expressivity in a family with unicentric and idiopathic multicentric Castleman disease

    Blood Advances, Vol. 2, Núm. 21, pp. 2959-2963

2017

  1. 18F-FDG PET/CT in the clinical management of patients with lymphoma

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 36, Núm. 5, pp. 312-321

2016

  1. Population pharmacokinetics of doxorubicin and doxorubicinol in patients diagnosed with non-Hodgkin's lymphoma

    British Journal of Clinical Pharmacology, Vol. 82, Núm. 6, pp. 1517-1527

2015

  1. A novel, fully automated, observer-independent program for semiquantifying striatal 123I-FP-CIT uptake

    Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 34, Núm. 2, pp. 89-94

  2. Incidence and risk factors for life-threatening bleeding after allogeneic stem cell transplant

    British Journal of Haematology, Vol. 169, Núm. 5, pp. 719-725

2014

  1. Therapeutic options in relapsed or refractory peripheral T-cell lymphoma

    Cancer Treatment Reviews, Vol. 40, Núm. 9, pp. 1080-1088

2013

  1. Estimation of the total effective dose from low-dose CT scans and radiopharmaceutical administrations delivered to patients undergoing SPECT/CT explorations

    Annals of Nuclear Medicine, Vol. 27, Núm. 7, pp. 610-617

  2. Limbic hyperactivity associated to verbal memory deficit in schizophrenia

    Journal of Psychiatric Research, Vol. 47, Núm. 6, pp. 843-850

  3. To freeze or not to freeze peripheral blood stem cells prior to allogeneic transplantation from matched related donors

    European Journal of Haematology, Vol. 91, Núm. 5, pp. 448-455